High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner

Oliver J. Taylor, Mikayla O. Thatcher, Sheryl T. Carr, Jonathan L. Gibbs, Annie M. Trumbull, Mitchell E. Harrison, Duane R. Winden, Mackenzie J. Pearson, Trevor S. Tippetts, William L. Holland, Paul R. Reynolds, Benjamin T. Bikman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We have previously found that cigarette smoke disrupts metabolic function, in part, by increasing muscle ceramide accrual. To further our understanding of this, we sought to determine the role of the cytokine high-mobility group box 1 (HMGB1), which is increased with smoke exposure, in smoke-induced muscle metabolic perturbations. To test this theory, we determined HMGB1 from lungs of human smokers, as well as from lung cells from mice exposed to cigarette smoke. We also treated cells and mice directly with HMGB1, in the presence or absence of myriocin, an inhibitor of serine palmitoyltransferase, the rate-limiting enzyme in ceramide biosynthesis. Outcomes included assessments of insulin resistance and muscle mitochondrial function. HMGB1 was significantly increased in both human lungs and rodent alveolar macrophages. Further testing revealed that HMGB1 treatment elicited a widespread increase in ceramide species and reduction in myotube mitochondrial respiration, an increase in reactive oxygen species, and reduced insulin-stimulated Akt phosphorylation. Inhibition of ceramide biosynthesis with myriocin was protective. In mice, by comparing treatments of HMGB1 injections with or without myriocin, we found that HMGB1 injections resulted in increased muscle ceramides, especially C16 and C24, which were necessary for reduced muscle mitochondrial respiration and compromised insulin and glucose tolerance. In conclusion, HMGB1 may be a necessary intermediate in the ceramide-dependent metabolic consequences of cigarette smoke exposure.

Original languageEnglish (US)
Article number1099
JournalInternational Journal of Molecular Sciences
Volume18
Issue number5
DOIs
StatePublished - May 20 2017

Fingerprint

Ceramides
smoke
Smoke
Tobacco Products
Muscle
boxes
muscles
Muscles
Insulin
insulin
Biosynthesis
Lung
lungs
mice
Respiration
Serine C-Palmitoyltransferase
biosynthesis
respiration
Phosphorylation
Injections

Keywords

  • Ceramides
  • Cigarette smoke
  • High-mobility group box 1 (HMGB1)
  • Mitochondrial bioenergetics

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Taylor, O. J., Thatcher, M. O., Carr, S. T., Gibbs, J. L., Trumbull, A. M., Harrison, M. E., ... Bikman, B. T. (2017). High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner. International Journal of Molecular Sciences, 18(5), [1099]. https://doi.org/10.3390/ijms18051099

High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner. / Taylor, Oliver J.; Thatcher, Mikayla O.; Carr, Sheryl T.; Gibbs, Jonathan L.; Trumbull, Annie M.; Harrison, Mitchell E.; Winden, Duane R.; Pearson, Mackenzie J.; Tippetts, Trevor S.; Holland, William L.; Reynolds, Paul R.; Bikman, Benjamin T.

In: International Journal of Molecular Sciences, Vol. 18, No. 5, 1099, 20.05.2017.

Research output: Contribution to journalArticle

Taylor, OJ, Thatcher, MO, Carr, ST, Gibbs, JL, Trumbull, AM, Harrison, ME, Winden, DR, Pearson, MJ, Tippetts, TS, Holland, WL, Reynolds, PR & Bikman, BT 2017, 'High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner', International Journal of Molecular Sciences, vol. 18, no. 5, 1099. https://doi.org/10.3390/ijms18051099
Taylor, Oliver J. ; Thatcher, Mikayla O. ; Carr, Sheryl T. ; Gibbs, Jonathan L. ; Trumbull, Annie M. ; Harrison, Mitchell E. ; Winden, Duane R. ; Pearson, Mackenzie J. ; Tippetts, Trevor S. ; Holland, William L. ; Reynolds, Paul R. ; Bikman, Benjamin T. / High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner. In: International Journal of Molecular Sciences. 2017 ; Vol. 18, No. 5.
@article{c1fa82e14dd9401bbde91e2cdc9ca048,
title = "High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner",
abstract = "We have previously found that cigarette smoke disrupts metabolic function, in part, by increasing muscle ceramide accrual. To further our understanding of this, we sought to determine the role of the cytokine high-mobility group box 1 (HMGB1), which is increased with smoke exposure, in smoke-induced muscle metabolic perturbations. To test this theory, we determined HMGB1 from lungs of human smokers, as well as from lung cells from mice exposed to cigarette smoke. We also treated cells and mice directly with HMGB1, in the presence or absence of myriocin, an inhibitor of serine palmitoyltransferase, the rate-limiting enzyme in ceramide biosynthesis. Outcomes included assessments of insulin resistance and muscle mitochondrial function. HMGB1 was significantly increased in both human lungs and rodent alveolar macrophages. Further testing revealed that HMGB1 treatment elicited a widespread increase in ceramide species and reduction in myotube mitochondrial respiration, an increase in reactive oxygen species, and reduced insulin-stimulated Akt phosphorylation. Inhibition of ceramide biosynthesis with myriocin was protective. In mice, by comparing treatments of HMGB1 injections with or without myriocin, we found that HMGB1 injections resulted in increased muscle ceramides, especially C16 and C24, which were necessary for reduced muscle mitochondrial respiration and compromised insulin and glucose tolerance. In conclusion, HMGB1 may be a necessary intermediate in the ceramide-dependent metabolic consequences of cigarette smoke exposure.",
keywords = "Ceramides, Cigarette smoke, High-mobility group box 1 (HMGB1), Mitochondrial bioenergetics",
author = "Taylor, {Oliver J.} and Thatcher, {Mikayla O.} and Carr, {Sheryl T.} and Gibbs, {Jonathan L.} and Trumbull, {Annie M.} and Harrison, {Mitchell E.} and Winden, {Duane R.} and Pearson, {Mackenzie J.} and Tippetts, {Trevor S.} and Holland, {William L.} and Reynolds, {Paul R.} and Bikman, {Benjamin T.}",
year = "2017",
month = "5",
day = "20",
doi = "10.3390/ijms18051099",
language = "English (US)",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - High-mobility group box 1 disrupts metabolic function with cigarette smoke exposure in a ceramide-dependent manner

AU - Taylor, Oliver J.

AU - Thatcher, Mikayla O.

AU - Carr, Sheryl T.

AU - Gibbs, Jonathan L.

AU - Trumbull, Annie M.

AU - Harrison, Mitchell E.

AU - Winden, Duane R.

AU - Pearson, Mackenzie J.

AU - Tippetts, Trevor S.

AU - Holland, William L.

AU - Reynolds, Paul R.

AU - Bikman, Benjamin T.

PY - 2017/5/20

Y1 - 2017/5/20

N2 - We have previously found that cigarette smoke disrupts metabolic function, in part, by increasing muscle ceramide accrual. To further our understanding of this, we sought to determine the role of the cytokine high-mobility group box 1 (HMGB1), which is increased with smoke exposure, in smoke-induced muscle metabolic perturbations. To test this theory, we determined HMGB1 from lungs of human smokers, as well as from lung cells from mice exposed to cigarette smoke. We also treated cells and mice directly with HMGB1, in the presence or absence of myriocin, an inhibitor of serine palmitoyltransferase, the rate-limiting enzyme in ceramide biosynthesis. Outcomes included assessments of insulin resistance and muscle mitochondrial function. HMGB1 was significantly increased in both human lungs and rodent alveolar macrophages. Further testing revealed that HMGB1 treatment elicited a widespread increase in ceramide species and reduction in myotube mitochondrial respiration, an increase in reactive oxygen species, and reduced insulin-stimulated Akt phosphorylation. Inhibition of ceramide biosynthesis with myriocin was protective. In mice, by comparing treatments of HMGB1 injections with or without myriocin, we found that HMGB1 injections resulted in increased muscle ceramides, especially C16 and C24, which were necessary for reduced muscle mitochondrial respiration and compromised insulin and glucose tolerance. In conclusion, HMGB1 may be a necessary intermediate in the ceramide-dependent metabolic consequences of cigarette smoke exposure.

AB - We have previously found that cigarette smoke disrupts metabolic function, in part, by increasing muscle ceramide accrual. To further our understanding of this, we sought to determine the role of the cytokine high-mobility group box 1 (HMGB1), which is increased with smoke exposure, in smoke-induced muscle metabolic perturbations. To test this theory, we determined HMGB1 from lungs of human smokers, as well as from lung cells from mice exposed to cigarette smoke. We also treated cells and mice directly with HMGB1, in the presence or absence of myriocin, an inhibitor of serine palmitoyltransferase, the rate-limiting enzyme in ceramide biosynthesis. Outcomes included assessments of insulin resistance and muscle mitochondrial function. HMGB1 was significantly increased in both human lungs and rodent alveolar macrophages. Further testing revealed that HMGB1 treatment elicited a widespread increase in ceramide species and reduction in myotube mitochondrial respiration, an increase in reactive oxygen species, and reduced insulin-stimulated Akt phosphorylation. Inhibition of ceramide biosynthesis with myriocin was protective. In mice, by comparing treatments of HMGB1 injections with or without myriocin, we found that HMGB1 injections resulted in increased muscle ceramides, especially C16 and C24, which were necessary for reduced muscle mitochondrial respiration and compromised insulin and glucose tolerance. In conclusion, HMGB1 may be a necessary intermediate in the ceramide-dependent metabolic consequences of cigarette smoke exposure.

KW - Ceramides

KW - Cigarette smoke

KW - High-mobility group box 1 (HMGB1)

KW - Mitochondrial bioenergetics

UR - http://www.scopus.com/inward/record.url?scp=85020019166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020019166&partnerID=8YFLogxK

U2 - 10.3390/ijms18051099

DO - 10.3390/ijms18051099

M3 - Article

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 5

M1 - 1099

ER -